As deaths from an Ebola virus outbreak in the Democratic Republic of Congo and Uganda have risen above 80, the World Health ...

The FDA has approved AstraZeneca's aldosterone synthase inhibitor (ASI) – baxdrostat – for hard-to-treat hypertension, making ...

Regeneron has reported that its fianlimab antibody targeting LAG-3, an immune checkpoint proposed as a cancer target, has missed the mark in a highly anticipated melanoma trial. The phase 3 trial was ...

Yet, tell the council you’ve moved and you may still need to inform the school, your GP, the DVLA, and a range of other ...

The turmoil at the FDA continues with the news that Tracy Beth Høeg has been fired as acting head of the FDA's Center for ...

Germany's Merck KGaA is looking at making further acquisitions to boost its business, according to chief executive Belén Garijo. The CEO – who is due to step down next April after five years in the ...

Khalil Asmar, VP of cardiometabolic health at Lilly UK & Ireland (l), and former England spin bowler Ashley Giles (r). Like ...

Boehringer Ingelheim's alliance with digital health company Brainomix on an AI-enabled tool for diagnosing interstitial lung ...

Big Tech platforms continue to roll out AI health assistants at scale, with Amazon’s new agent the latest to be integrated ...

The Supreme Court of the US has ruled that the abortion pill mifepristone can continue to be prescribed remotely and delivered by mail-order, overruling an appeals court decision earlier this month.

In its second pipeline-expanding deal in the space of 24 hours, GSK has licensed rights to a drug for chronic obstructive pulmonary disease (COPD) from US biotech Empirico for $85 million upfront. The ...

Regenxbio is pitching at FDA approval next year for its Duchenne muscular dystrophy (DMD) gene therapy RGX-202, after ...